207 related articles for article (PubMed ID: 15782619)
21. Treatment of Mycobacterium avium Complex (MAC).
Griffith DE
Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550
[No Abstract] [Full Text] [Related]
22. A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes.
Aoki A; Jinno H; Ogawa K; Nakagawa T; Inagaki T; Wajima T; Okamoto Y; Uchiya KI
Microbiol Spectr; 2023 Feb; 11(1):e0432622. PubMed ID: 36622171
[TBL] [Abstract][Full Text] [Related]
23. [Nontuberculous mycobacterial pulmonary disease - The new ATS/ERS/ESCMID/IDSA Guideline].
Wagner D; Lange C
Dtsch Med Wochenschr; 2020 Aug; 145(16):1145-1151. PubMed ID: 32791550
[TBL] [Abstract][Full Text] [Related]
24. [Perspective of pulmonary MAC infection treatment].
Kurashima A
Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
[TBL] [Abstract][Full Text] [Related]
25. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
[TBL] [Abstract][Full Text] [Related]
26. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
Kuwabara K; Tsuchiya T
Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):587-92. PubMed ID: 17763685
[TBL] [Abstract][Full Text] [Related]
27. Comparison of clinical and radiographic characteristics between nodular bronchiectatic form of nontuberculous mycobacterial lung disease and diffuse panbronchiolitis.
Park HY; Suh GY; Chung MP; Kim H; Kwon OJ; Chung MJ; Kim TS; Lee KS; Koh WJ
J Korean Med Sci; 2009 Jun; 24(3):427-32. PubMed ID: 19543504
[TBL] [Abstract][Full Text] [Related]
28. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
29. [The short-term effects of multidrug chemotherapy for pulmonary Mycobacterium avium-intracellulare complex (MAC) infection].
Kurashima A
Kekkaku; 1998 May; 73(5):371-7. PubMed ID: 9637822
[TBL] [Abstract][Full Text] [Related]
30. [Overview of respiratory infection caused by nontuberculous mycobacteria].
Fujita J; Hibiya K; Haranaga S; Higa F; Tateyama M
Kekkaku; 2007 Sep; 82(9):721-7. PubMed ID: 17969990
[TBL] [Abstract][Full Text] [Related]
31. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
Kobashi Y; Matsushima T
Intern Med; 2003 Aug; 42(8):670-5. PubMed ID: 12924489
[TBL] [Abstract][Full Text] [Related]
32. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
Ramirez J; Mason C; Ali J; Lopez FA
J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection.
Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Handa M; Munekata E
J Int Med Res; 2004; 32(5):530-9. PubMed ID: 15458286
[TBL] [Abstract][Full Text] [Related]
34. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Lee G; Lee KS; Moon JW; Koh WJ; Jeong BH; Jeong YJ; Kim HJ; Woo S
Ann Am Thorac Soc; 2013 Aug; 10(4):299-306. PubMed ID: 23952847
[TBL] [Abstract][Full Text] [Related]
35. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
Watanabe M; Hasegawa N; Ishizaka A; Asakura K; Izumi Y; Eguchi K; Kawamura M; Horinouchi H; Kobayashi K
Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Prognosis and Antimycobacterial Glycolipid Antibody as Biomarker in Mycobacterium avium-intracellulare Complex Pulmonary Disease.
Maekura R; Miki K; Tateishi Y; Matsumoto S; Kitada S; Miki M; Kida H
Microbiol Spectr; 2022 Jun; 10(3):e0053022. PubMed ID: 35467367
[TBL] [Abstract][Full Text] [Related]
37. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Tomioka H; Sato K; Kajitani H; Akaki T; Shishido S
Antimicrob Agents Chemother; 2000 Feb; 44(2):283-6. PubMed ID: 10639351
[TBL] [Abstract][Full Text] [Related]
38. [Susceptibility to rifabutin and novel fluoroquinolones in Mycobacterium avium complex isolates from patients with sputum culture-positive pulmonary disease who are undergoing standard chemotherapy].
Tateishi Y; Motone M; Yoshimura K; Miki M; Miki K; Kitada S; Hashimoto H; Hiraga T; Maekura R
Nihon Kokyuki Gakkai Zasshi; 2010 Nov; 48(11):797-802. PubMed ID: 21141056
[TBL] [Abstract][Full Text] [Related]
39. Minimum inhibitory concentrations of azithromycin in clinical isolates of
Uwamino Y; Aoki W; Inose R; Kamoshita Y; Mikita K; Namkoong H; Nishimura T; Matsushita H; Hasegawa N
Microbiol Spectr; 2024 Jun; 12(6):e0021824. PubMed ID: 38687080
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
Hasegawa N; Nishimura T; Ohtani S; Takeshita K; Fukunaga K; Tasaka S; Urano T; Ishii K; Miyairi M; Ishizaka A
Chest; 2009 Dec; 136(6):1569-1575. PubMed ID: 19542259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
